We've found
						7,711
						 archived clinical trials in
						Depression
					
				We've found
						7,711
						 archived clinical trials in
						Depression
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
	
	Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
	
Updated: 9/23/2015
  
  
  	  A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
		Status: Enrolling	
	Updated: 9/23/2015
Click here to add this to my saved trials
		    
			
	Bone Mineral Density in Women With Major Depression
	
Updated: 9/26/2015
  
  
  Bone Mineral Density in Patients With Major Depression With Melancholic and Atypical Features: Relation to Stress-System Neurohormonal Function
		Status: Enrolling	
	Updated: 9/26/2015
	
	Bone Mineral Density in Women With Major Depression
	
Updated: 9/26/2015
  
  
  	  Bone Mineral Density in Patients With Major Depression With Melancholic and Atypical Features: Relation to Stress-System Neurohormonal Function
		Status: Enrolling	
	Updated: 9/26/2015
Click here to add this to my saved trials
		    
			
	NMDA Antagonists in Bipolar Depression
	
Updated: 9/28/2015
  
  
  NMDA Antagonists in Bipolar Depression
		Status: Enrolling	
	Updated: 9/28/2015
	
	NMDA Antagonists in Bipolar Depression
	
Updated: 9/28/2015
  
  
  	  NMDA Antagonists in Bipolar Depression
		Status: Enrolling	
	Updated: 9/28/2015
Click here to add this to my saved trials
		    
			
	Levetiracetam in the Management of Bipolar Depression
	
Updated: 9/29/2015
  
  
  Levetiracetam in the Management of Bipolar Depression
		Status: Enrolling	
	Updated: 9/29/2015
	
	Levetiracetam in the Management of Bipolar Depression
	
Updated: 9/29/2015
  
  
  	  Levetiracetam in the Management of Bipolar Depression
		Status: Enrolling	
	Updated: 9/29/2015
Click here to add this to my saved trials